Zimmer Biomet Holdings Return on Investment 2006-2018 | ZBH
Current and historical return on investment (ROI) values for Zimmer Biomet Holdings (ZBH) over the last 10 years.
| Zimmer Biomet Holdings ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2018-12-31 | $0.03B | $19.72B | 0.16% |
| 2018-09-30 | $0.79B | $20.82B | 3.76% |
| 2018-06-30 | $0.78B | $21.46B | 3.75% |
| 2018-03-31 | $0.77B | $21.49B | 3.76% |
| 2017-12-31 | $0.81B | $20.65B | 4.02% |
| 2017-09-30 | $1.02B | $19.65B | 5.10% |
| 2017-06-30 | $1.01B | $19.63B | 4.96% |
| 2017-03-31 | $0.93B | $20.47B | 4.55% |
| 2016-12-31 | $0.83B | $20.34B | 4.04% |
| 2016-09-30 | $0.86B | $20.75B | 4.13% |
| 2016-06-30 | $0.78B | $20.08B | 3.70% |
| 2016-03-31 | $0.44B | $20.78B | 2.07% |
| 2015-12-31 | $0.47B | $21.39B | 2.32% |
| 2015-09-30 | $0.48B | $21.68B | 2.83% |
| 2015-06-30 | $0.61B | $21.88B | 4.59% |
| 2015-03-31 | $1.01B | $15.64B | 10.14% |
| 2014-12-31 | $1.04B | $7.98B | 12.96% |
| 2014-09-30 | $1.16B | $7.97B | 14.55% |
| 2014-06-30 | $1.12B | $8.14B | 14.08% |
| 2014-03-31 | $1.07B | $7.92B | 13.68% |
| 2013-12-31 | $1.07B | $7.97B | 13.87% |
| 2013-09-30 | $0.92B | $7.83B | 12.12% |
| 2013-06-30 | $0.96B | $7.58B | 12.71% |
| 2013-03-31 | $1.05B | $7.42B | 14.00% |
| 2012-12-31 | $1.05B | $7.59B | 14.06% |
| 2012-09-30 | $1.05B | $7.57B | 14.29% |
| 2012-06-30 | $1.07B | $7.44B | 14.75% |
| 2012-03-31 | $1.02B | $7.23B | 14.29% |
| 2011-12-31 | $1.02B | $7.09B | 14.42% |
| 2011-09-30 | $0.95B | $7.15B | 13.40% |
| 2011-06-30 | $0.95B | $7.16B | 13.57% |
| 2011-03-31 | $0.92B | $7.01B | 13.26% |
| 2010-12-31 | $0.92B | $6.91B | 13.30% |
| 2010-09-30 | $1.03B | $6.96B | 15.06% |
| 2010-06-30 | $0.97B | $6.87B | 14.27% |
| 2010-03-31 | $1.03B | $6.84B | 15.52% |
| 2009-12-31 | $1.02B | $6.77B | 15.68% |
| 2009-09-30 | $1.02B | $6.58B | 16.10% |
| 2009-06-30 | $1.03B | $6.46B | 16.60% |
| 2009-03-31 | $1.04B | $6.22B | 17.22% |
| 2008-12-31 | $1.09B | $6.11B | 18.38% |
| 2008-09-30 | $1.20B | $5.95B | 20.76% |
| 2008-06-30 | $1.12B | $5.83B | 19.82% |
| 2008-03-31 | $1.13B | $5.82B | 20.50% |
| 2007-12-31 | $1.13B | $5.55B | 20.98% |
| 2007-09-30 | $1.11B | $5.36B | 21.25% |
| 2007-06-30 | $1.24B | $5.38B | 24.23% |
| 2007-03-31 | $1.20B | $5.22B | 23.90% |
| 2006-12-31 | $1.17B | $5.02B | 23.43% |
| 2006-09-30 | $1.11B | $4.91B | 22.57% |
| 2006-06-30 | $1.10B | $4.98B | 22.65% |
| 2006-03-31 | $1.09B | $5.01B | 23.01% |
| 2005-12-31 | $1.06B | $4.76B | 22.82% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $25.203B | $7.933B |
| Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The company design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Zimmer Biomet Holdings, Inc., formerly known as Zimmer Holdings, Inc., is based in Warsaw, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $131.725B | 26.04 |
| Medtronic (MDT) | Ireland | $124.003B | 18.10 |
| Stryker (SYK) | United States | $69.357B | 25.46 |
| Boston Scientific (BSX) | United States | $55.158B | 26.93 |
| Baxter (BAX) | United States | $39.096B | 24.09 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.703B | 0.00 |
| ResMed (RMD) | United States | $14.294B | 27.11 |
| Canopy Growth (CGC) | Canada | $10.770B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.091B | 51.74 |
| Hill-Rom Holdings (HRC) | United States | $6.945B | 21.48 |
| Aurora Cannabis (ACB) | Canada | $6.920B | 49.50 |
| Perrigo (PRGO) | Ireland | $6.732B | 10.22 |
| ICU Medical (ICUI) | United States | $5.180B | 28.86 |
| Insulet (PODD) | United States | $5.177B | 0.00 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $4.529B | 0.00 |
| Haemonetics (HAE) | United States | $4.482B | 39.76 |
| Agios Pharmaceuticals (AGIO) | United States | $3.370B | 0.00 |
| Hutchison China MediTech (HCM) | China | $3.317B | 0.00 |
| Neogen (NEOG) | United States | $3.262B | 50.11 |
| NuVasive (NUVA) | United States | $2.949B | 27.43 |
| Quidel (QDEL) | United States | $2.670B | 24.08 |
| National Vision Holdings (EYE) | United States | $2.583B | 49.97 |
| Aphria (APHA) | $2.429B | 107.89 | |
| NxStage Medical (NXTM) | United States | $1.977B | 0.00 |
| AtriCure (ATRC) | United States | $1.267B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.231B | 17.70 |
| VAREX IMAGING (VREX) | United States | $1.213B | 23.75 |
| Cardiovascular Systems (CSII) | United States | $1.191B | 854.75 |
| HEXO (HEXO) | $1.180B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.936B | 0.00 |
| Cerus (CERS) | United States | $0.886B | 0.00 |
| PetIQ (PETQ) | United States | $0.833B | 21.60 |
| Surmodics (SRDX) | United States | $0.773B | 112.39 |
| Lantheus Holdings (LNTH) | United States | $0.737B | 19.96 |
| Meridian Bioscience (VIVO) | United States | $0.728B | 21.70 |
| Evolus (EOLS) | United States | $0.725B | 0.00 |
| NanoString Technologies (NSTG) | United States | $0.718B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.707B | 31.16 |
| Omeros (OMER) | United States | $0.681B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.624B | 20.02 |
| Quanterix (QTRX) | United States | $0.505B | 0.00 |
| Owens & Minor (OMI) | United States | $0.494B | 6.84 |
| LeMaitre Vascular (LMAT) | United States | $0.492B | 23.46 |
| Insys Therapeutics (INSY) | United States | $0.418B | 0.00 |
| TG Therapeutics (TGTX) | United States | $0.398B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.339B | 21.99 |
| BioLife Solutions (BLFS) | United States | $0.322B | 435.25 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.293B | 0.00 |
| Vapotherm (VAPO) | United States | $0.285B | 0.00 |
| Bovie Medical (APYX) | United States | $0.281B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.259B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.253B | 0.00 |
| Zynex (ZYXI) | United States | $0.170B | 16.42 |
| Surface Oncology (SURF) | United States | $0.147B | 0.00 |
| Fonar (FONR) | United States | $0.146B | 7.79 |
| Chembio Diagnostics (CEMI) | United States | $0.116B | 0.00 |
| Chimerix (CMRX) | United States | $0.097B | 0.00 |
| United-Guardian (UG) | United States | $0.090B | 18.77 |
| Female Health (VERU) | United States | $0.085B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.083B | 0.00 |
| CAS Medical Systems (CASM) | United States | $0.070B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.064B | 17.80 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.057B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.057B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| Neurotrope (NTRP) | United States | $0.034B | 0.00 |
| Senestech (SNES) | United States | $0.022B | 0.00 |
| Myomo (MYO) | United States | $0.017B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.013B | 0.00 |
| InVivo Therapeutics Holdings (NVIV) | United States | $0.013B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.011B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.010B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 14.29 |
